您现在的位置: 首页> 研究主题> GST融合蛋白

GST融合蛋白

GST融合蛋白的相关文献在1996年到2019年内共计66篇,主要集中在分子生物学、基础医学、生物化学 等领域,其中期刊论文62篇、会议论文1篇、专利文献161173篇;相关期刊47种,包括科技经济市场、生物工程学报、生物化学与生物物理进展等; 相关会议1种,包括第四届全国青年精细化工学术会议等;GST融合蛋白的相关文献由282位作者贡献,包括陈凤玲、黄鹤、任建科等。

GST融合蛋白—发文量

期刊论文>

论文:62 占比:0.04%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:161173 占比:99.96%

总计:161236篇

GST融合蛋白—发文趋势图

GST融合蛋白

-研究学者

  • 陈凤玲
  • 黄鹤
  • 任建科
  • 宋怀东
  • 彭虹
  • 李晓萌
  • 李遂焰
  • 杨南扬
  • 沈嘉娟
  • 王凤山

GST融合蛋白

-相关会议

  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 董育红; 李遂焰; 陈渝萍
    • 摘要: 鉴于纤维化疾病病人组织中I型胶原的异常沉积和人胎盘生长因子2氨基酸123~144肽段(PlGF-2123-144)对I型胶原蛋白出众的高亲性,尝试制备PlGF-2123-144短肽用于改善抗纤维化药物的组织靶向特异性.首先对该短肽的编码DNA序列进行修改和扩增,构建了GST-PlGF-2123-144融合蛋白的原核表达质粒;进而使用E.coli BL21诱导表达该融合蛋白,并以谷胱甘肽琼脂糖纯化后透析;最后采用ELISA检测确定,经原核表达和纯化所获得的GST-PlGF-2123-14融合蛋白具备对I型胶原蛋白的高亲性.为研发特异性靶向纤维化组织的抗纤维化药物打下了可靠基础.
    • 尹淑琴; 常泓; 范艳; 朱宏; 梁娟
    • 摘要: 为了鉴定重组UK114基因工程菌是否稳定表达,并进行初步的高细胞密度发酵试验.将重组基因工程菌BL21 (DE3)/pGEX--4T-3-UK 114进行菌种的传代培养并酶切检测;在保持菌种不变情况下,在5L高密度发酵罐中,采用补料分批培养方法进行高密度发酵.结果表明,重组基因工程菌BL21(DE3)/pGEX-4T-3-UK114传代20代后质粒稳定存在,高密度发酵结束菌体浓度OD600大于50,融合蛋白量占菌体总蛋白量的31%,其含量达到2.1 g/L,工程菌获高效表达.
    • 范芳芳; 孙慧莹; 徐晖; 刘佳玮; 张海员; 李亦兰; 宁雪莲; 孙悦; 白静
    • 摘要: 利用Gateway克隆技术构建重组抗瘤肽AIK的原核表达体系,建立表达及纯化重组AIK的最优条件,为深入研究和利用AIK奠定基础.首先,设计含AttB重组位点的引物,通过重叠PCR技术扩增出AttB-TEV-FLAG-AIK序列,利用BP重组反应将目的序列TEV-FLAG-AIK克隆到供体载体pDONR223中,构建入门载体,再通过LR重组反应,将目的序列转移到目的载体pDEST15中,构建GST-AIK融合蛋白原核表达质粒.随后,在BL21 (DE3)工程菌中优化诱导融合蛋白表达的条件.以谷胱甘肽磁珠纯化GST-AIK融合蛋白,再以rTEV酶切除GST,获得FLAG-AIK重组蛋白.最后以MTS法检测FLAG-AIK对白血病细胞HL-60的细胞毒性.菌液PCR验证和测序分析表明成功构建了重组抗瘤肽AIK的入门质粒和原核表达质粒.在BL21(DE3)工程菌中实现了GST-AIK融合蛋白的高效可溶性表达.并测得在37°C下以0.1 mmol/L IPTG诱导工程菌(OD600=1.0)4 h,重组蛋白表达量占菌体总蛋白的30%以上.经GST亲和层析、rTEV酶切除GST标签及二次GST亲和层析获得纯度高于95%的FLAG-AIK蛋白.MTS法测得所制备的FLAG-AIK蛋白抑瘤活性与化学合成的AIK相当.总之,本课题应用Gateway克隆系统成功构建了抗瘤肽AIK的原核表达质粒,实现了GST-AIK融合蛋白的高效可溶性表达,经亲和层析获得了有生物活性的重组AIK多肽,为后续深入研究和大规模制备奠定了基础.
    • 丁月霞; 倪琼琼; 刘金来
    • 摘要: Objective: To design a recombinant polypeptide vaccine specific to group A β-hemolytic streptococcus serotypes M1 and M12 protein; and clone the gene sequences of the designed vaccine and construct a recombinant vector( pGEX-4T-1-emml/12-J14, pE) containing fragments of emml gene and emml2 gene that is the type specific epitopes of M protein and J14 sequence variants in the conserved C-terminal region of M protein; so that to induce the expression of GST fusion protein(GST/emm). MethodS;A recombinant polypeptide vaccine was designed by linking 35 amino acids after signal peptide separately from M1 and M12 protein and a common conservative sequence J14 which showed certain immunogenicity but no cross reaction with human tissue protein in the order of M1-12-J14, and analyzed for homology of amino acids to that of human tissue protein by blast to NCBI data bank. A group of above oli-gonucleotides was synthesized by overlap PCR, in which the restriction sites of BamH I and Xho I were introduced at 5' and 3' terminus respectively. The synthetic sequence was digested with BamH I and Xho I and cloned into cloning vector pGEX-4T-1 (pG) , and the constructed recombinant plasmid was identified by sequencing. Furthermore to induce and optimize the expression of GST/emm with IPTG at different times(2 ,6,8 ,18 and 24 h) or different concentrations(0. 01 mmol/L,0. l mmol/L and 1.0 mmol/L)and under different temperatures(25°C ,30°C and 37°C ) ; last to check and identify the gel sample of GST/emm with MALDI-TOF. Results: 1. The gene sequence of designed vaccine was successfully cloned, and a recombinant cloning vector(pGEX-4T-1-emml/12-J14,pE)carrying designed gene sequence was obtained;2. Using this plasmid, we have achieved over expression of soluble recombinant polypeptide as a GST fusion protein using E. coli BL21 strain, under optimized environmental factors such as culture time (the maximum during 6-8 h induced) and inducer (IPTG) concentration (the optimal concentration 1.0 mmol/L ) ,but it seems that induced temperature had no significant effects on the the expression of GST/emm(under different temperature, GST /emm always over expressed ) ;3. GST/emm gel sample with designed amino acids was identified with SDS-PAGE or Western blot. Conclusion: We have first constructed a recombinant expression plasmid (pGEX-4T-1-emml/12-J14,pE) , in which we merged recombinant polypeptide with the glutathione S-trans- ferees (GST) coding sequence downstream of the tac-inducible promoter and successfully induce and optimize GST fusion protein expression.%目的:设计针对A组β溶血性链球菌M1和M12蛋白的复合多肽;构建含M蛋白基因(emm基因)1型和12型特异性抗原决定簇基因及其保守区J14肽基因的GST标签的重组表达载体;并诱导和优化GST融合蛋白的表达.方法:在NCBI Genebank和Olig0 6引物设计软件中选择分别编码M蛋白emm基因1型和12型信号肽后35个氨基酸及其相同的保守区14肽基因序列(全长270 bp),通过重叠PCR(Overlap PCR)合成所需的核苷酸序列,经测序确定序列完全和设计的相匹配后,将该重组片段克隆到pGEX-4T-1表达载体中,阳性克隆经双酶切和测序鉴定正确后建立稳定表达该重组质粒的大肠杆菌BL21株系(pE/B);通过聚丙烯酰胺凝胶的考马斯亮蓝染色和Western blot来检测在不同时间(O、2、6、8、18和24小时)和温度(25°C、30°C和37°C)以及不同浓度(0.01、0.1、1 mmol/L)异丙基-β-D-硫代吡喃半乳糖苷(IPTG)诱导GST融合蛋白(GST/emm)表达情况,并对诱导表达的GST/emm切胶进行质谱分析鉴定.结果:成功构建含有emml和emm12抗原决定簇及M蛋白保守区J14肽基因的原核表达载体;并诱导其稳定表达,在1 mol/L IPTG诱导6~8小时达高峰,不同温度下均有过量表达;质谱检测诱导蛋白GST/emm条带结果正确.结论:成功构建A组p溶血性链球菌的emm1型和emm12型原核表达载体,并稳定诱导GST/emm表达,为下一步研究GST/emm的纯化、酶切以及免疫原性的鉴定和疫苗研制打下夯实的基础.
    • 胡其娴; 马晓文; 胡小磊; 沈琼娜; 王晶; 陈凤玲
    • 摘要: 目的 OC-STAMP蛋白是一种功能尚不明确的六次跨膜蛋白,通过制备多克隆抗体来为进一步研究其功能奠定基础.方法 采用PCR技术扩增出目的基因,将其克隆到pGEX-4T-1原核表达载体中.经IPTG诱导后,重组质粒pGEX-4T-1/OC-STAMP表达含重组谷胱甘肽转移酶(GST)的融合蛋白GST-OC-STAMP.GST-OC-STAMP融合蛋白经纯化后免疫新西兰大白兔,制备多克隆抗体.此后应用ELISA及Western blot方法鉴定该抗体.结果 pGEX-4T-1/OC-STAMP重组质粒构建成功,并通过原核表达获得达到免疫要求的融合蛋白.免疫所得抗体血清经间接ELISA法、Western blot检测,确定获得了高效价的小鼠OC-STAMP多克隆抗体.结论 成功制备了小鼠OC-STAMP抗体,为进一步研究基因功能奠定了基础.%Objective To prepare the polyclonal antibody of a transmembrane protein mouse OC-STAMP whose function is unclear for the following function study.Methods Target gene was amplified by PCR and cloned into prokaryotic expression vector pGEX-4T-1,so the recombinant prokaryotic expression vector pGEX-4T-1/OC-STAMP was constructed,and the corresponding fusion protein GST-OC-STAMP was induced with IPTG.After purification,GST-OC-STAMP fusion protein was used to immunize New Zealand rabbits to prepare polyclonal antibody.Thereafter,the antibody was detected by ELISA and Western blot.Results Recombinant prokaryotic expression vector and GST fusion protein for immunization were prepared.After immuning,the mouse OC-STAMP polyclonal antibody which we got was tested with indirect ELISA and Western blot,in order to make sure that specific polyclonal antibody was generated successfully.Conclusions Preparation of mouse OC-STAMP polyclonal antibody was successful,which laid the foundations for further study of mouse OC-STAMP in the future.
    • 刘彤; 李洋; 李丹妮; 耿楠希; 李丰
    • 摘要: 目的:构建人p21活化激酶6(PAK6)的各个截短区域原核表达质粒,并诱导和鉴定其融合蛋白的表达,为探讨PAK6基因的生物学功能提供依据.方法:以真核表达质粒pcDNA3.1-GFP-PAK6为模板,PCR扩增出PAK6基因的各个截短片段.所获得的各截短片段经EcoR Ⅰ/Xho Ⅰ双酶切后克隆至GST标签的原核表达载体pGEX-5X-1中.将构建的PAK6各截短质粒转化入Ecoli BL21中,采用IPTG诱导PAK6基因截短融合蛋白表达,采用Western blotting法鉴定PAK6基因截短融合蛋白的表达.结果:EcoR Ⅰ/Xho Ⅰ双酶切后得到与预期大小相符的载体片段(5 000 bp)和PAK6 1-55(165 bp)、PAK6 56-210(465 bp)、PAK6 211-410(600 bp)及PAK6 385-681(891 bp)4个片段.Western blotting检测,PAK6各截短区域质粒GST-PAK6截短融合蛋白相对分子质量分别为32 000、43 000、48 000和60 000.结论:成功构建PAK6基因各个截短区域GST标签原核表达质粒并表达其重组蛋白.
    • 陈洋; 何泽; 张永臣; 万青; 赵虎子; 赵蕾; 沈传陆
    • 摘要: Objective: To construct pGEX-MLC2 recombinant plasmid and to express and purify GST-MLC2 fusion protein .The fusion protein was prepared for MLC 2 polyclonal antibody .Methods: The total RNA was extracted from human breast cancer cells MCF-7, the full-length open reading frame ( ORF) of MLC2 cDNA was amplified by RT-PCR and then was cloned into the expression vector pGEX-6P-1.After identification by restriction enzyme digestion analysis and DNA sequencing , the recombinant clone was transformed into the competent cells E. coli BL21.GST-MLC2 fusion protein was induced expression by IPTG and was identified by Western blotting;Then the fusion protein was purified by Glutathione Sepharose 4 B affinity chromatography and the purity was identified by SDA-PAGE electrophoresis .Results: The RT-PCR product of MLC2 was 535 bp in line with expectations; The recombinant plasmid of pGEX-MLC2 was identified containing a distinctive 525 bp fragment by BamH I and EcoR I double digestion;DNA sequencing confirmed that the MLC 2 full-length ORF sequence was correct .The molecular weight of GST-MLC2 fusion protein by IPTG induced expression was about 46.6 kDa and the purity of GST-MLC2 fusion protein was about 95%after purification .Western blotting analysis proved that the protein was GST-MLC2 fusion protein .Conclusion:The construction of prokaryotic expression plasmid for human MLC 2 protein and the expression and purification of GST-MLC2 fusion protein lay the foundations for the preparation of MLC 2 antibody and the further study on the function of MLC 2.%目的:构建pGEX-MLC2重组质粒,在大肠杆菌中表达并纯化谷胱甘肽硫转移酶( GST )-MLC2融合蛋白,以用于MLC2抗体的制备。方法:从人乳腺癌MCF-7细胞中提取总RNA,通过RT-PCR获得人MLC2 cDNA全长开放读码框架(open reading frame, ORF),并将其重组于原核蛋白表达质粒pGEX-6P-1中,经限制性内切酶和DNA测序鉴定,将该重组质粒转化大肠杆菌E.coli BL21,用异丙基β-D-硫代半乳糖苷( IPTG)诱导表达 GST-MIC2融合蛋白后,进行 Western blotting 分析,鉴定 GST-MLC2蛋白;通过 Glutathione Sepharose 4B亲和层析柱纯化融合蛋白,并用SDS-PAGE电泳鉴定该融合蛋白的纯度。结果:人乳腺癌MCF-7细胞MLC2的RT-PCR产物为535 bp,符合预期;重组质粒pGEX-MLC2经BamHI和EcoRI双酶切出现特征性的525 bp片段;DNA测序证实MLC2全长ORF序列正确无误。 IPTG诱导表达的GST-MLC2融合蛋白分子质量约为46.6 kDa,纯化后其蛋白纯度约95%,经Western blotting 分析表明诱导表达的蛋白是GST-MLC2融合蛋白。结论:人MLC2蛋白原核表达质粒的构建、GST-MLC2融合蛋白的表达和纯化,为MLC2抗体的制备及MLC2功能的深入研究奠定了基础。
    • 白露; 胡斌; 杨艳; 段昌柱
    • 摘要: Objective To construct domain -based GST (glutathione-S-transferase) fusion mutant expressing vectors of UHRF2, purify and verify all the prokaryotically expressed proteins for downstream purpose. Methods DNA fragments of each domain of UHRF2 were amplified by PCR method; the PCR products were digested with restriction enzymes and incorporated into pGEX -4T-1 vector. All established mutants were expressed in the transformed BL21 strain of E. coli by IPTG induction. The GST-fusion mutants containing bacteria were collected , sonicated and purified for the proteins using Glutathione Sepharose 4B. Purified proteins were subjected to SDS -PAGE followed by CBB staining or immunobloting assay. Results All the domain -based GST fusion mutants of UHRF2 were constructed successfully into prokaryotic expressing vectors and prokaryotically expressed prod -ucts were purified and confirmed. Conclusion The constructed domain -based mutants of UHRF2 can be used in GST pull-down assay to study UHRF2 domains that may be implicated in its partner association, thus enabling further understanding of UHRF 2.%目的 构建 UHRF2 各个以结构域为基础的突变体原核表达载体,在大肠埃希菌中表达并对融合蛋白进行纯化和鉴定.方法 以 pCMV-3xFlag-UHRF2 为模板,PCR 扩增 UHRF2 的各个结构域基因片段,各 PCR 产物经酶切后连接到 pGEX-4T-1 载体上;将重组载体转化大肠埃希菌 (BL21菌株),IPTG 诱导表达各 GST 融合蛋白,超声波破碎细菌,离心收获蛋白并经谷胱甘肽琼脂糖凝胶 4B(glutathione sepharose 4B) 亲合纯化;纯化的蛋白经 SDS-PAGE 电泳后用考马斯亮蓝染色或免疫印记实验鉴定各蛋白表达情况.结果 成功构建了 UHRF2 结构域突变体的原核表达载体,各突变体蛋白表达正确.结论 UHRF2 各结构域突变体的成功构建便于用 GST pull-down 实验研究 UHRF2 参与与其它蛋白相互作用的结构域,为了解UHRF2 功能打下了基础.
    • 刘卉芳; 刘晓燕; 张惠洁; 胡小磊; 胡其娴; 马晓文; 陈凤玲
    • 摘要: Objective To prepare the polyclonal antibody of an unknown cytosolic protein KIAA1199 for the following function study.Methods Target genes were amplified by PCR and cloned into prokaryotic expression vector pMAL-C2X and pGEX-5X-1,so the recombinant prokaryotic expression vector pMAL-C2X/KIAA1199 and pGEX-5X-1/KIAA1199 were constructed,and the corresponding fusion proteins maltose binding protein MBP-KIAA1199 and GST-KIAA1199 were induced with IPTG separately.After purification,MBP-KIAA1199 fusion protein was used to immunize New Zealand rabbits to prepare polyclonal antibody,and GST-KIAA1199 was used to identify the specificity of the new antibody.Thereafter,the antibody was detected by Western blot and ELISA.Results Two recombinant prokaryotic expression vectors were constructed successfully,and specific polyclonal antibodies were also generated.Conclusions Preparation of KIAA1199 polyclonal antibody successfully,which may lay foundation to investigating the function of KIAA1199 gene in the future.%目的 KIAA1199是一种功能未知的胞浆蛋白,通过制备多克隆抗体来为进一步研究其功能奠定基础.方法 采用PCR技术扩增出目的基因,将其克隆到pMAL-C2X和pGEX-5X-1原核表达载体中.经IPTG诱导后,重组质粒pMAL-C2X/KIAA1199和pGEX-5X-1/KIAA1199,分别表达含麦芽糖结合蛋白(MBP)的MBP-KIAA1199融合蛋白和含重组谷胱甘肽转移酶(GST)的融合蛋白GST-KIAA1199.其中,MBP-KIAA1199融合蛋白经纯化后,免疫新西兰大白兔,制备多克隆抗体;GST-KIAA1199融合蛋白用于检测抗体特异性.此后应用ELISA及Western blot方法鉴定该抗体.结果 pMAL-C2X/KIAA1199和pGEX-5X-1/KIAA1199两个重组质粒构建成功,并获得了高效价的特异性多克隆抗体.结论 成功制备了KIAA1199抗体,为进一步研究基因功能奠定了基础.
    • 熊志红; 朱琰; 李仁德; 庄玉辉; 程小星
    • 摘要: Objective To build the expression vector of Mycobacterium tuberculosis PPE19-GST fusion protein and identify its expression in E. coli. Methods The PPE19 gene was amplified from H37Rv genome using PCR method, then cloned into pGEX-kg vector. The expressive vector pGEX-PPE19 was transformed into E. coli DH5a. The expression of GST-PPE19 fusion protein was detected by SDS-PAGE and Werstem-blot. Results The result of restriction enzyme digestion and nucleotide sequencing confirmed that the recombi-nant plasmids were correct. The recombinant GST-PPE19 expression was about 70 kDa, in the form of solution in E. coli DHSa. Conclusion The recombinant PPE19 proteins were successfully expressed, which laid foundation for further function study of PPE19 of Mycobacterium tuberculosis.%目的 构建结核分枝杆菌PPE19的GST融合蛋白表达载体,并鉴定其在大肠杆菌中的表达.方法 以结核杆菌H37Rv基因组为模板,根据PPE19基因序列设计引物,运用PCR的方法获得PPE19基因,并将其克隆到pGEX-kg载体中,转化大肠杆菌DH5α,挑取阳性菌落进行质粒的酶切和序列分析;将构建正确的克隆进行诱导表达,对菌体裂解物进行SDS-PAGE分析;用western-blot鉴定融合蛋白的表达.结果 正确构建了pGEX-PPE19原核表达载体,载体上基因序列正确;载体能在大肠杆菌中表达分子量约为70 kDa的重组蛋白;该蛋白能与GST抗体结合.结论 成功构建了GST-PPE19融合蛋白的表达载体,为进一步进行PPE19蛋白的功能研究奠定了基础.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号